Dr. Ferhana Najam, MD

Dr. Najam practices at Emory Specialty Associates in Decatur, Georgia.

Dr. Najam's NPI, 1568706653, was assigned on November 15, 2012. Dr. Najam holds Georgia license 077091.

Dr. Najam's primary practice is Emory Specialty Associates, at 101 W Ponce De Leon Ave, Decatur, GA 30030 in Dekalb County. The practice phone is (404) 778-4888.

Dr. Najam's primary practice is Emory Specialty Associates in Decatur, Georgia. Dr. Najam is also affiliated with Emory Decatur Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Najam to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Najam practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Najam's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Najam is licensed in Georgia.

CMS data shows 253 Medicare services from Dr. Najam across 3 procedure codes in 2024, all of them office visits, for 120 Medicare patients. Medicare paid $25,095 for them.

CMS counts 120 Medicare patients who saw Dr. Najam in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have arthritis, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Najam's median patient age at 65, with 82% women.

In 2024, Dr. Najam wrote 3,105 Medicare Part D claims for 401 patients. 83% of them were for generic drugs. CMS names the drug for 2,962 of them, across 46 drugs with 11 or more claims each, at $2,994,508 in total drug cost. In 2023, CMS named 2,771 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Najam for performance year 2024, reported through an alternative payment model (APM). Dr. Najam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Najam as offering telehealth.

CMS Open Payments shows 208 general payments to Dr. Najam from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Amgen Inc. paid the most, $628.